(Q44551911)

4 December 2017

Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100. (English)

1 reference

4 December 2017

1 reference

Ashish K Pathak

3

0 references

author name string

Dante J Marciani

1

1 reference

4 December 2017

Robert C Reynolds

2

1 reference

4 December 2017

Kyra Finley-Woodman

4

1 reference

4 December 2017

Richard D May

5

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

21

1 reference

4 December 2017

25-26

1 reference

4 December 2017

3961-3971

1 reference

Mechanisms of stimulation of the immune response by aluminum adjuvants

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Degradation of Quillaja saponaria Molina saponins: loss of the protective effects of a herpes simplex virus 1 subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

QS-21 structure/function studies: effect of acylation on adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Quillaja saponin adjuvants: derivatives formed under sub-optimal conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Adjuvant activity of QS-21 isomers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Separation and structural analysis of saponins in a bark extract from Quillaja saponaria Molina

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Triterpenoid saponins from Quillaja saponaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Covalent chemical events in immune induction: fundamental and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Structural studies of triterpenoid saponins with new acyl components from Quillaja saponaria Molina

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Structural and immunological characterization of the vaccine adjuvant QS-21.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Recent advances in vaccine adjuvants for systemic and mucosal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

The arthritogenic adjuvant squalene does not accumulate in joints, but gives rise to pathogenic cells in both draining and non-draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

What are the limits of adjuvanticity?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900298-6

7 January 2021

10.1016/S0264-410X(03)00298-6

Identifiers

DOI

1 reference

4 December 2017

1 reference